Format

Send to

Choose Destination
Clin Liver Dis. 2009 May;13(2):249-66. doi: 10.1016/j.cld.2009.02.009.

Nonalcoholic fatty liver disease: a practical approach to evaluation and management.

Author information

1
Center for Liver Diseases at Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA.

Abstract

Non-alcoholic fatty liver disease (NAFLD) has become one of the most common forms of chronic liver disease in the Western world. The rise in NAFLD is thought to be associated with the prevalence of metabolic syndrome. NASH is a subtype of NAFLD that may progress to cirrhosis and end stage liver disease. Although there are no approved treatment regimens for NAFLD or NASH, a number of different interventions are being tested. Meanwhile, most experts advocate that components of metabolic syndrome should be effectively treated.

PMID:
19442917
DOI:
10.1016/j.cld.2009.02.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center